코로나바이러스감염증-19에서 나타나는 후미각손상의 특성과 한의학적 분석
Features and Interpretation of Olfactory and Gustatory Disorders in the Corona Virus Disease-19
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Besides respiratory infection, COVID-19 has many neurological symptoms not only loss of smell and taste but also fatigue and brain fog. But it is a challenge to treat the neurological symptoms especially of anosmia and ageusia. In order to search for the therapeutic methods, the geographical diversity and pathological mechanisms of the COVID-19 and two symptoms were investigated from the latest clinical studies. Because the environmental conditions of the monsoon climate zone of East Asia and the Mediterranean and Oceanic climate zone of Italy, Britain, United States and tropical Brazil are different, each of diverse etiology and internal milieu should be considered differently in the treatment. SARS-CoV-2 exhibits the dampness-like characteristics and the olfactory and gustatory disorders are particularly more common than other flu or cold. and it tends to show features of damaging the lung qi of olfaction and heart-spleen qi of gustation. The mechanisms of olfactory and gustatory loss are various according to precursory, inflammatory, non-inflammatory and sequelar forms, so the therapeutic method should be designed for each period and pathology. If the process of inflammation arises from nasal and respiratory, olfactory epithelium to the central nervous structure by way of blood brain barrier, the treatment should be corresponded with the stage and depth of pathogen place. And if the olfactory loss is asymptomatic or in the initial stage, it can be applied intranasal topical scent therapy to relieve temporary locking of qi movement, but maybe also used in parallel together with herbs of relieving dampness toxin latent in the lung parenchyma.
Abstract
Besides respiratory infection, COVID-19 has many neurological symptoms not only loss of smell and taste but also fatigue and brain fog. But it is a challenge to treat the neurological symptoms especially of anosmia and ageusia. In order to search for the therapeutic methods, the geographical diversity and pathological mechanisms of the COVID-19 and two symptoms were investigated from the latest clinical studies. Because the environmental conditions of the monsoon climate zone of East Asia and the Mediterranean and Oceanic climate zone of Italy, Britain, United States and tropical Brazil are different, each of diverse etiology and internal milieu should be considered differently in the treatment. SARS-CoV-2 exhibits the dampness-like characteristics and the olfactory and gustatory disorders are particularly more common than other flu or cold. and it tends to show features of damaging the lung qi of olfaction and heart-spleen qi of gustation. The mechanisms of olfactory and gustatory loss are various according to precursory, inflammatory, non-inflammatory and sequelar forms, so the therapeutic method should be designed for each period and pathology. If the process of inflammation arises from nasal and respiratory, olfactory epithelium to the central nervous structure by way of blood brain barrier, the treatment should be corresponded with the stage and depth of pathogen place. And if the olfactory loss is asymptomatic or in the initial stage, it can be applied intranasal topical scent therapy to relieve temporary locking of qi movement, but maybe also used in parallel together with herbs of relieving dampness toxin latent in the lung parenchyma.
참고문헌 (61)
- Hui DS, "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China", Int J Infect Dis, 91, pp.264~266 (2019)
- "WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020"[URL]
- Chauhan S., "Comprehensive review of coronavirus disease 2019 (COVID-19)", Biomedical Journal[DOI]
- "Coronavirus disease 2019 (COVID-19) Situation Report-52"[URL]
- "COVID-19 information"[URL]
- "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia(Trial Version 7)" (2020)[URL]
- "Labour and Welfare" (2020)[URL]
- "(Exclusive) Daegu 15% of 3191 confirmed patients lost their sense of smell or taste. Article in Korean" (2020)[URL]
- Zhu KZ, "Preliminary study of China's climate change in the last 5,000 years", Archaeological Journal, (1), pp.168~188 (1972)
- "Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7) Traditional Chinese medicine (TCM) treatment", ~ (2020)
- "New Corona Virus Pneumonia (Trial 8th Edition)" (2020)[URL]
- Zhang R, "Three cases of COVID-19 pneumonia imported from outside Tianjin", CHIN ARCH OTOLARYNGOL HEAD NECK SURG, 27(6), pp.305~306 (2020)
- Council of Respiratory Internal medicine of Korean Medicine College, "Korean Medicine Guidelines on Coronavirus Disease-19", ~ (2020)
- Council of Respiratory Internal medicine of Korean Medicine College, "Korean Medicine Guidelines on Coronavirus Disease-19, Ver. 2.1", ~ (2020)
- Yonghyun Lee, "Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients", Journal of Korean Medical Science, 35(18), pp.1~6 (2020), 대한의학회[DOI]
- Lechien JR, "Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study", Eur Arch Otorhinolaryngol. (2020)[DOI]
- Giacomelli A, "Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study", Clin Infect Dis (2020)[DOI]
- Eliezer M, "Sudden and complete olfactory loss function as a possible symptom of COVID-19", JAMA Otolaryngol Head Neck Surg, 146(7), pp.674~675 (2020)[DOI]
- Jang YE, "Olfactory and taste disorder: The first and only sign in a patient with SARS-CoV-2 pneumonia", Infection Control & Hospital Epidemiology, 41, pp.1103~1125 (2020)[DOI]
- "News on Medicine, health, Nursing & explanation, Admission of 3 Hanshin baseball players" (2020)[URL]
- "Regarding the outbreak of new coronavirus infections (COVID-19) patients" (2020)[URL]
- "Guideline to New Coronavirus Infectious Diseases COVID-19 Medical Treatment 2.1 Edition" (2020)[URL]
- Nakagawara K, "Acute Onset Olfactory", Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections, 2020, ~
- Lechner M, "Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection, (Correspondence)", The Lancet Microbe, 1 (2020)[DOI]
- G Torre, "Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study", J. Clin. Med, 9, pp.2870~ (2020)[DOI]
- Giacomelli A, "Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study", Clin Infect Dis (2020)[DOI]
- Vaira LA, "Anosmia and ageusia: common findings in COVID-19 patients", Laryngoscope (2020)[DOI]
- Lechien JR, "Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study", Eur Arch Otorhinolaryngol (2020)[DOI]
- Lechien JR, "Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019", J Intern Med. (2019)[DOI]
- Kosugia E, "Incomplete and late recovery of sudden olfactory dysfunction in COVID-19", Braz. j. otorhinolaryngol., 86(4) (2020)
- Valéria Barcelos Daher, "Anosmia: A marker of infection by the new corona virus", Respiratory Medicine Case Reports, 31 (2020)
- Sofia Mermelstein, "Acute anosmia from COVID-19 infection", Pract Neurol (2020)[DOI]
- Yan CH, "Self-reported olfactory loss associates with outpatient clinical course in COVID-19", Int Forum Allergy Rhinol (2020)[DOI]
- Agyeman A, "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis", Mayo Clin Proc, 95(8), pp.1621~1631 (2020)[DOI]
- Weekly national Influenza and COVID19 surveillance report, "Public Health England", ~, pp.Week 42 report (2020)
- "COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE)"[URL]
- e-Vol 1, "Harrison’s Principles of Internal Medicine, 15", pp.2003, Braunwald F
- van der Hoek L, "Human coronaviruses: what do they cause?", Antivir Ther(Lond), 12, pp.651~658 (2007)
- Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia", N Engl J Med, 367, pp.1814~1820 (2012)
- Benoit G, "Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission", Lancet, 381, pp.2265~2272 (2013)
- "director of the Beijing Traditional Chinese Medicine Hospital, returned from Wuhan to talk about the new type of coronavirus pneumonia" (2020)[URL]
- Ye YD, "Is there a cure for Wuhan Chinese pneumonia? Guangdong approves treatment of pneumonia 1 hao for milder patients", Journal For a Better Life (2020)
- Chen J, "Practice and understanding of traditional Chinese medicine in real world treatment of nover coronavirus pneumonia: Reflection on diagnosis and treatment in a primary designated hospital", Jourmal of Clinical Medicine in Practice, 24(4) (2020)[DOI]
- XIANG Q, "Traditional Chinese Medicine Theory and Clinical Study on Novel Coronavirus Pneumonia(NCP)Infection", Herald of Medicine, 39(3), pp.323~326 (2020)[DOI]
- Pairo-Castineira E, "Genetic mechanisms of critical illness in COVID-19", Preprint from medRxiv, 25 Sep 2020. DOI: 10.1101, 2020 (2020)
- Baj J, "COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge", J. Clin. Med, 9, pp.1753~ (2020)[DOI]
- Kanjanaumporn J, "Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options", Asian Pac J Allergy Immunol, 38, pp.69~77 (2020)[DOI]
- Christopher HH, "The Neurology of Olfaction", pp.22~23 (2009), Cambridge University Press
- Hwang CS, "Olfactory neuropathy in severe acute respiratory syndrome: report of A case", Acta Neurol Taiwan, 15(1), pp.26~28 (2006)
- Beltran-Corbellini A, "Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicenter PCR-based case- control study", Eur J Neurol (2020)[DOI]
- Vaira LA, "Anosmia and Ageusia: Common Findings in COVID-19 Patients", Laryngoscope (2020)[DOI]
- Yixuan J, "SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract", Cell, 182(2), pp.429~446 e14 (2020)
- Brann D, "Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia", Science Advances, 6(31) (2020)[DOI]
- Rafal B, "SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection", ACS Chem Neurosci. (2020)[DOI]
- XIANG Q, "Traditional Chinese Medicine Theory and Clinical Study on Novel Coronavirus Pneumonia(NCP)Infection", Herald of Medicine, 39(3), pp.323~326 (2020)[DOI]
- Majid F, "Neurobiology of COVID-19", Journal of Alzheimer's Disease, 76(1), pp.3~19 (2020)[DOI]
- Duan YP, "Exploratory analysis of lung-gastric correlation", Shanxizhongyi, 12, pp.1104~1106 (2003)[DOI]